Effects of Hot Baths Prior or After a Damaging Protocol on Muscle Function and HSP70 Expression

NCT07559344 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2026-04-30

No results posted yet for this study

Summary

Muscle lengthening contractions lead to physiological responses such as strength loss, soreness, immune cell infiltration, and CK production, along with elevated heat shock proteins (HSPs), which protect and regenerate cells. Passive heating before or after exercise can aid in recovery by restoring strength and reducing soreness, requiring a core temperature of over 38.5°C for 20 minutes to be effective. Studies show that combined mechanical and thermal stress induces a cumulative HSP response, enhancing cellular protection. Thermal stress alone peaks at 16- 24 hours, whereas mechanical stress shows a biphasic response, with peaks at 3-6 hours and around 39 hours. Thus, combining heat with exercise could optimize HSP production, improving recovery by increasing and accelerating the HSP response. However, more research is needed to determine the best timing for thermal stress in human applications, especially in sports and therapy contexts.

This study aimed to compare the effects of hot-water immersion administered before versus after muscle-lengthening exercise on muscle function and HSP70 expression in healthy young athletes.

Conditions

  • Recovery
  • Mechanical Stress
  • Heat Stress
  • HSP70
  • Cumulative Response
  • Hot-water Immersion

Interventions

OTHER

Immersion

Immersion lasted 40 minutes with the goal of reaching a core temperature of 38.5°C in the heat-stress groups

OTHER

NIRS

NIRS

OTHER

isokinetic dynamometer

isokinetic dynamometer

OTHER

pressure algometer

pressure algometer

OTHER

Hokanson armband

Hokanson armband

Sponsors & Collaborators

  • CH CORBIE

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-16
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07559344 on ClinicalTrials.gov